Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells

Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells

US Patent 8252958 · Granted Aug 28, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hydrazone derivatives for preventing or treating EBV-related cancers2022
Compounds for treating cystic fibrosis2019
Use of purine derivatives for the production of medicaments for the treatment of2013
Use of glucosidase inhibitors for therapy of mucovisidosis2012
Screening molecules with anti-prion activity: kits, methods and screened molecul2012
Use of glucosidase inhibitors for therapy of mucovisidosis2011
Use of chlorine guanabenz derivatives for treating polyglutamine expansion assoc2011
Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are 2011
CFTR channel modulators2010
Use of paullone derivatives for the production of medicaments for the treatment 2009
CFTR channel activator compounds and pharmaceutical compositions containing same2003